143 related articles for article (PubMed ID: 22303820)
1. Underuse of aspirin for primary and secondary prevention of cardiovascular disease events in women.
Rivera CM; Song J; Copeland L; Buirge C; Ory M; McNeal CJ
J Womens Health (Larchmt); 2012 Apr; 21(4):379-87. PubMed ID: 22303820
[TBL] [Abstract][Full Text] [Related]
2. Aspirin use among adults aged 40 and older in the United States: results of a national survey.
Pignone M; Anderson GK; Binns K; Tilson HH; Weisman SM
Am J Prev Med; 2007 May; 32(5):403-407. PubMed ID: 17478266
[TBL] [Abstract][Full Text] [Related]
3. Effects of changing guidelines on prescribing aspirin for primary prevention of cardiovascular events.
Hissett J; Folks B; Coombs L; Leblanc W; Pace WD
J Am Board Fam Med; 2014; 27(1):78-86. PubMed ID: 24390889
[TBL] [Abstract][Full Text] [Related]
4. Frequency and practice-level variation in inappropriate aspirin use for the primary prevention of cardiovascular disease: insights from the National Cardiovascular Disease Registry's Practice Innovation and Clinical Excellence registry.
Hira RS; Kennedy K; Nambi V; Jneid H; Alam M; Basra SS; Ho PM; Deswal A; Ballantyne CM; Petersen LA; Virani SS
J Am Coll Cardiol; 2015 Jan; 65(2):111-21. PubMed ID: 25593051
[TBL] [Abstract][Full Text] [Related]
5. A review and study of aspirin utilization for the primary prevention of cardiovascular events in a psychiatric population.
Victor K; Skelly M; Mulcahy K; Demler TL; Trigoboff E
Int Clin Psychopharmacol; 2018 Sep; 33(5):274-281. PubMed ID: 29939889
[TBL] [Abstract][Full Text] [Related]
6. A national survey on aspirin patterns of use and persistence in community outpatients in Italy.
Filippi A; Bianchi C; Parazzini F; Cricelli C; Sessa E; Mazzaglia G
Eur J Cardiovasc Prev Rehabil; 2011 Oct; 18(5):695-703. PubMed ID: 21450601
[TBL] [Abstract][Full Text] [Related]
7. Underutilization of aspirin persists in US ambulatory care for the secondary and primary prevention of cardiovascular disease.
Stafford RS; Monti V; Ma J
PLoS Med; 2005 Dec; 2(12):e353. PubMed ID: 16277554
[TBL] [Abstract][Full Text] [Related]
8. Aspirin for primary prevention of cardiovascular disease events.
Nemerovski CW; Salinitri FD; Morbitzer KA; Moser LR
Pharmacotherapy; 2012 Nov; 32(11):1020-35. PubMed ID: 23019080
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness model of use of genetic testing as an aid in assessing the likely benefit of aspirin therapy for primary prevention of cardiovascular disease.
Shiffman D; Slawsky K; Fusfeld L; Devlin JJ; Goss TF
Clin Ther; 2012 Jun; 34(6):1387-94. PubMed ID: 22560621
[TBL] [Abstract][Full Text] [Related]
10. Aspirin for primary prevention: yes or no?
Selak V; Elley CR; Wells S; Rodgers A; Sharpe N
J Prim Health Care; 2010 Jun; 2(2):92-9. PubMed ID: 20690297
[TBL] [Abstract][Full Text] [Related]
11. Update on aspirin in the treatment and prevention of cardiovascular disease.
Hennekens CH
Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
[TBL] [Abstract][Full Text] [Related]
12. Aspirin use among U.S. adults: Behavioral Risk Factor Surveillance System.
Ajani UA; Ford ES; Greenland KJ; Giles WH; Mokdad AH
Am J Prev Med; 2006 Jan; 30(1):74-7. PubMed ID: 16414427
[TBL] [Abstract][Full Text] [Related]
13. Adherence to therapies for secondary prevention of cardiovascular disease: a focus on aspirin.
Packard KA; Hilleman DE
Cardiovasc Ther; 2016 Dec; 34(6):415-422. PubMed ID: 27473898
[TBL] [Abstract][Full Text] [Related]
14. Mis-medication and Under-utilization of Aspirin in the Prevention and Treatment of Cardiovascular Disease.
Cook NR; Chae C; Mueller FB; Landis S; Saks AM; Hennekens CH
MedGenMed; 1999 Nov; ():E1. PubMed ID: 11104403
[TBL] [Abstract][Full Text] [Related]
15. Application of U.S. guidelines in other countries: aspirin for the primary prevention of cardiovascular events in Japan.
Morimoto T; Fukui T; Lee TH; Matsui K
Am J Med; 2004 Oct; 117(7):459-68. PubMed ID: 15464702
[TBL] [Abstract][Full Text] [Related]
16. Aspirin for primary prevention of cardiovascular disease in women.
Jneid H
Methodist Debakey Cardiovasc J; 2010 Nov-2011 Jan; 6(4):37-42. PubMed ID: 21088658
[TBL] [Abstract][Full Text] [Related]
17. Use of aspirin for primary and secondary cardiovascular disease prevention in the United States, 2011-2012.
Mainous AG; Tanner RJ; Shorr RI; Limacher MC
J Am Heart Assoc; 2014 Jul; 3(4):. PubMed ID: 25023071
[TBL] [Abstract][Full Text] [Related]
18. National study of physician awareness and adherence to cardiovascular disease prevention guidelines.
Mosca L; Linfante AH; Benjamin EJ; Berra K; Hayes SN; Walsh BW; Fabunmi RP; Kwan J; Mills T; Simpson SL
Circulation; 2005 Feb; 111(4):499-510. PubMed ID: 15687140
[TBL] [Abstract][Full Text] [Related]
19. Aspirin for primary prevention of cardiovascular disease?
Drug Ther Bull; 2009 Nov; 47(11):122-5. PubMed ID: 19887685
[TBL] [Abstract][Full Text] [Related]
20. Are at-risk New Zealand women receiving recommended cardiovascular preventive therapy?
Bupha-Intr O; Rose SB; Lawton BA; Elley CR; Dowell AC
N Z Med J; 2010 Feb; 123(1309):26-36. PubMed ID: 20186240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
